Last update 01 Nov 2024
Shanghai Xunhe Pharmaceutical Technology Co., Ltd
Last update 01 Nov 2024
Overview
Tags
Neoplasms
Other Diseases
Immune System Diseases
Small molecule drug
Chemical drugs
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
一项评价XH-5102片口服给药在骨髓增殖性肿瘤患者中的安全性、耐受性、药代动力学特征和初步疗效的I/II期研究
[Translation] A Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of XH-5102 Orally Administered Tablets in Patients with Myeloproliferative Neoplasms
评价XH-6003注射液在中国健康成年受试者中单次给药的一项随机、双盲、单中心、安慰剂对照、剂量递增的安全性和耐受性以及药代动力学的Ⅰ期临床研究
[Translation] A randomized, double-blind, single-center, placebo-controlled, dose-escalation Phase I clinical study to evaluate the safety, tolerability, and pharmacokinetics of a single dose of XH-6003 injection in healthy Chinese adult subjects
一项评价XH-30002胶囊口服给药在晚期实体瘤患者中的安全性、耐受性、药代动力学特征和初步疗效的Ⅰ期临床研究
[Translation] A Phase I clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of oral XH-30002 capsules in patients with advanced solid tumors
100 Clinical Results associated with Shanghai Xunhe Pharmaceutical Technology Co., Ltd
Login to view more data
Login to view more data
100 Deals associated with Shanghai Xunhe Pharmaceutical Technology Co., Ltd
Login to view more data
100 Translational Medicine associated with Shanghai Xunhe Pharmaceutical Technology Co., Ltd
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 07 Nov 2024
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
1
2
Phase 1 Clinical
Phase 2 Clinical
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free